Sam Eiber

Stock Analyst at BTIG

(1.21)

# 3,340

Out of 4,829 analysts

4

Total ratings

50%

Success rate

-2.9%

Average return

Main Sectors:

Top Industries:

Medical Devices Drug Manufacturers - Specialty & Generic

Stocks Rated by Sam Eiber

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	INMD InMode	Downgrades: Neutral	n/a	$15.00	-	2	Apr 29, 2025
	EOLS Evolus	Initiates: Buy	$21	$9.98	+110.42%	1	Apr 17, 2025
	APYX Apyx Medical	Initiates: Neutral	n/a	$1.11	-	1	Oct 17, 2024

InMode

Apr 29, 2025

Downgrades: Neutral

Price Target: n/a

Current: $15.00

Upside: -

Evolus

Apr 17, 2025

Initiates: Buy

Price Target: $21

Current: $9.98

Upside: +110.42%

Apyx Medical

Oct 17, 2024

Initiates: Neutral

Price Target: n/a

Current: $1.11

Upside: -